0 CHECKOUT

PRODUCT FILTERS

REGION

77
27
21
17
16

COUNTRY

21
11
5
3
2

CATEGORIES

  • 150
  • 44
  • 38
  • 31
  • 30
  • 27
  • 26
  • 22
  • 21
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 14
  • 12
  • 11
  • 11
  • 9
  • 9
  • 9
  • 9
  • 8
  • 8
  • 8
  • 8
  • 8
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

426
480
515
652

PUBLISHED

15
37
122
652

PRODUCT TYPE

420
166
33
16
7
2
2
2
2
1
1

Search for: "Metabolic Syndrome"

Metabolic Syndrome-Pipeline Insights, 2016

“Metabolic Syndrome-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Metabolic Syndrome. The Report covers the product profiles...

Published:  August 2016
Price:  From

Diabetes, Metabolic Syndrome and Cardiovascular Disease

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease...

Published:  January 2016
Price:  From

Metabolic Syndrome - Pipeline Review, H1 2014

Metabolic Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metabolic Syndrome - Pipeline Review, H1 2014’, provides an overview of the Metabolic Syndrome’s therapeutic pipeline. This...

Published:  March 2014
Price:  From

Metabolic Syndrome - Pipeline Review, H2 2013

Metabolic Syndrome - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

Published:  September 2013
Price:  From

Metabolic Syndrome - Pipeline Review, H2 2012

Metabolic Syndrome – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

Published:  September 2012
Price:  From

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018

It is estimated that the 2013 sales for the Cushing’s syndrome (CS) therapeutic market was approximately $179m across the 6MM covered in this report. Pharmaceutical and biotechnology companies that...

Published:  January 2015
Price:  From

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H2 2015

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H2 2015 Summary The report ‘Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H2 2015’, provides an overview...

Published:  September 2015
Price:  From

Metabolic Syndrome - Pipeline Review, H1 2012

Metabolic Syndrome – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, H1 2012', provides an overview of the Metabolic Syndrome therapeutic pipeline....

Published:  March 2012
Price:  From

Nutritional And Therapeutic Interventions For Diabetes and Metabolic Syndrome

Diabetes mellitus affects approximately 20 million people in the US, or nearly 7% of the population. It is expected to increase by 70% within the next 25 years, and numerous epidemiologic studies have...

Published:  March 2012
Price: 

Metabolic Syndrome and Neurological Disorders

Metabolic syndrome is a recognized suite of biological risk factors that increase the likelihood of developing long–term health problems including a wide range of neurological disorders. Metabolic Syndrome...

Published:  November 2013
Price: 

Metabolic Syndrome - Pipeline Review, Q4 2010

Metabolic Syndrome - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Metabolic Syndrome    Pipeline Review, Q4 2010”, provides an overview of the Metabolic Syndrome    therapeutic pipeline....

Published:  December 2010
Price:  From

Metabolic Syndrome - Pipeline Review, H2 2011

Metabolic Syndrome - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, H2 2011', provides an overview of the Metabolic Syndrome therapeutic pipeline....

Published:  October 2011
Price:  From

Metabolic Syndrome - Pipeline Review, Q1 2011

Metabolic Syndrome - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, Q1 2011', provides an overview of the Metabolic Syndrome therapeutic pipeline....

Published:  March 2011
Price:  From

Cushing's Syndrome - Pipeline Review, H1 2012

Cushing's Syndrome – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Cushing's Syndrome - Pipeline Review, H1 2012', provides an overview of the Cushing's Syndrome therapeutic pipeline....

Published:  April 2012
Price:  From

Global Cushing's Syndrome Therapeutics Market 2015-2019

About Cushing's Syndrome Cushing's syndrome is a condition caused by the prolonged exposure to very high levels of cortisol. This can occur because of the consumption of glucocorticoid drugs or diseases...

Published:  November 2014
Price:  From

Cushing's Syndrome - Pipeline Review, H2 2011

Cushing's Syndrome - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Cushing's Syndrome - Pipeline Review, H2 2011', provides an overview of the Cushing's Syndrome therapeutic pipeline....

Published:  August 2011
Price:  From

Metabolic Syndrome and Cardiovascular Disease. 2nd Edition

Trends indicate that the metabolic syndrome will become the leading risk factor for heart disease. Now more than ever you need an all–in–one reference that provides the tools and practical advice you...

Published:  September 2012
Price: 

Cushing's syndrome (CS) - Market Insights, Epidemiology and Market Forecast-2020

Cushing’s syndrome (CS) - Market Insights, Epidemiology and Market Forecast-2020 Reports provides an overview of the disease and global market trends for the seven major markets ie: United States,...

Published:  April 2016
Price:  From

Therapeutic Strategies for the Metabolic Syndrome

The metabolic syndrome is characterised by the presence in a particular individual of a number of metabolic risk factors that combine to put that patient at an increased risk of coronary artery disease,...

Published:  August 2008
Price:  From

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Cushing’s Syndrome - Epidemiology Forecast to 2023 Summary Cushing’s syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids,...

Published:  December 2014
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group